Balancing growth and green At The George Institute, we’re on an exciting journey to make sustainability a core part of everything we do. Our Sustainability Roadmap sets out how we’ll get there. In 2024, we’re laying the groundwork by finalizing our sustainability plan, conducting a thorough audit to understand where we stand, and listening to our stakeholders to learn what matters most to them. In 2025, we’ll start putting our plans into action—introducing initiatives to improve our performance, building better systems for tracking and reporting our progress, and tackling any gaps in the data we need to measure success. By 2026, we’ll focus on refining our processes, ensuring our data is accurate and reliable, and aligning with global frameworks to prepare for external reporting. Finally, in 2027, we’ll bring it all together by fully integrating climate reporting into our annual reporting cycles, ensuring sustainability is firmly embedded in how we work an

Program overview: Health and well-being are intrinsically impacted by socio-determinants related to carers, family, community, and service delivery across health and other sectors, within local country context. Socio-determinants are complex and can include dispossession, institutional racism, drug and alcohol, and debt, resulting in a lack of access to culturally safe services and intergenerational mistrust of services. However, sustainably integrating services within health and other sectors is challenging due to patient, organisational and policy and historical barriers.Our program aims to strengthen health systems resilience using interdisciplinary implementation research across different contexts, cultures and sectors, to holistically address socio-determinants of health so as to improve health equity. Program Objectives:  Examine and implement best practices in community engagement, partnerships and capacity-strengthening.  Embed WHO integrated people-centred

Our multilateral relationships harness the power of combined action, collaborating with others to address the world's leading causes of death and disability. WHO Civil Society CommissionThe George Institute is a member of the WHO Civil Society Commission, a global platform that strengthens dialogue and collaboration between WHO and civil society. Through this Commission, we contribute to a collective effort to provide strategic recommendations that enhance WHO's engagement with civil society at global, regional and national levels. As part of a broader network that includes a Steering Committee, annual General Meetings, and thematic Working Groups, our participation helps advance WHO's mission to achieve health for all, support the objectives of the WHO General Programme of Work, and accelerate progress toward the health‑related Sustainable Development Goals.Learn more WHO Global Clinical Trials ForumThe George Institute is a member of the WHO’s Global Clinical Trials Forum, a glob

We work with civil society groups and networks at local, regional and global levels, sharing evidence and identifying opportunities to influence health-related decisions. Our collective advocacy aims to build momentum and drive changes that reduce inequities and improve the health of millions of people worldwide. Action for Global Health UKLearn moreMore info about Action for Global Health UKAction for Global Health (AfGH) is a network of over 50 organizations working in global health. They connect members with key decision-makers, provide opportunities for joint advocacy and campaigning, and foster a collaborative community to drive progress towards Sustainable Development Goal 3 (Good Health and Well-being).Visit the website UK Working Group on NCDsLearn moreMore info about UK Working Group on NCDsThe UK Working Group on NCDs is a coalition of over 20 UK-based civil society organizations focused on non-communicable diseases (NCDs) as a critical international development issue. Their

What are clinical trials? Clinical trials are research studies with humans, designed to test new treatments to find better ways to prevent, detect or treat disease1. Clinical trials are also sometimes referred to as interventional trials. The sorts of treatments being investigated include medicines or drugs, cells and other biological products, surgical procedures, radiologic procedures, devices, behavioural treatments, process-of-care changes, preventive care, and other items.2 Clinical trials rely on having members of the general public agree to take part. What happens in a clinical trial? In a clinical trial, participants meet with researchers who go through what the clinical trial will involve. All participants must be advised about the objectives of the research, what is expected of them, as well as any risks that may be experienced during and after the trial. Trials must follow a carefully controlled protocol, which is a plan that describes what researchers will do in the stu

The Centre for Operational and Research Excellence (CORE) is a global group and provides high-quality expertise as well as robust operations, systems and processes to deliver The George Institute’s research strategy. CORE’s strategy is to: Achieve and maintain quality and integrity in research Build core skills and capacity in research operations Build and maintain robust systems and processes to enable and support research operations Knowledge management in research operations across The George Institute CORE’s functional activities include: Data Management: DM planning, database build and maintenance, quality data management practices, data cleaning, data sharing processes Project operations: budget development for funding applications, project start-up, implementation and close-out to high quality standards Research strategy and services: funding applications, internal grant programs, research capacity development

Researchers at The George Institute for Global Health, UK, led by Executive Director Professor Otavio Berwanger, are spearheading a programme of work to transform that way we deliver large-scale clinical trials. This programme is borne out of a recognition of the limitations of the ‘traditional’ clinical trial model – and the health gains (social, environmental and economic) – to be had in investigating pragmatic, innovative and efficient approaches. In both the so-called ‘traditional’ and innovative trial models, the gold standard of randomisation controls for both known and unknown confounding factors that could influence trials outcomes, and represents the optimal method to work out whether a healthcare intervention reduces the risk of patient-important outcomes and so inform clinical practice. Where the two models differ is that the traditional approach requires participants be screened and recruited in a trial site by a team of investigators, and so demands both a

Since 2019, the Health 10x Accelerator has supported Australia's brightest health and medtech entrepreneurs in developing affordable and scalable solutions to the world's most pressing unmet health and medical needs. Delivered in partnership with UNSW, the 10-week program provides startups with funding, mentorship, and resources to navigate regulatory pathways, refine investment strategies, and scale globally. Key partners and supporters, including Virtus Health, UNSW Tyree Institute of Health Engineering (IHealthE), Platypus MedTech Consulting, Genesys Electronics Design, Randwick Health & Innovation Precinct, Liverpool Innovation Precinct and AstraZeneca, offer additional support in coaching, investment, and specialised expertise. With the support of our partners and collaborators, startups can gain access to state-of-the-art facilities, collaboration spaces, and commercialisation specialists, enhancing their ability to create impactful solutions that transform global health outc

For over a decade, our award-winning digital platform SMARThealth has already been empowering frontline community health workers to identify, refer and manage early signs of cardiovascular disease in local communities in India and Indonesia. Over a decade later, our technology is evolving, now using a bespoke large language model chatbot to remove in-built gender bias in guideline-based advice for pregnant women. In Australia, we’re using machine learning to be able to predict the risk of cardiovascular disease in women using routine screening mammography, which could potentially lead to a low cost “two for one” screening test that may be more accurate than traditional methods. SMARThealth ChatGPT : Supporting community health workers to provide guideline-based maternal care in rural IndiaLearn more Predicting cardiovascular risk using routine mammograms Learn more

Soul Patts nurtures our future tech leaders to bring game-changing health solutions to life.

The George Institute’s founders are building on their pioneering vision with a transformational, million-dollar investment.